Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine-Reference-Cited by-同舟云学术

Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine

Published:2020-03 Issue:11 Volume:38 Page:2572-2577
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Hendry Alexandra J.,Beard Frank H.,Dey Aditi,Quinn Helen,Hueston Linda,Dwyer Dominic E.,McIntyre Peter B.

Funder

Australian Government Department of Health

NSW Ministry of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. Centers for Disease Control & Prevention. Poliomyelitis. In: Hamborsky J, Kroger A, Wolfe S (editors). Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington D.C: Public Health Foundation; 2015.

2. Polio vaccines: WHO position paper - March, 2016;World Health Organization;Wkly Epidemiol Rec,2016

3. World Health Organization. Poliomyelitis - Fact sheet.2017. Available from: http://www.who.int/mediacentre/factsheets/fs114/en/.

4. World Health Organization. International travel and health - Poliomyelitis (Polio). Available from: https://www.who.int/ith/diseases/polio/en/ [Accessed 22 January 2020].

5. Global Polio Eradication Initiative. Global eradication of wild poliovirus type 2 declared, 20 September 201201Available from: http://www.polioeradication.org/mediaroom/newsstories/Global-eradication-of-wild-poliovirus-type-2-declared/tabid/526/news/1289/Default.aspx [Accessed 15 June 2016].

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biocompatible nanocarriers an emerging platform for augmenting the antiviral attributes of bioactive polyphenols: A review;Journal of Drug Delivery Science and Technology;2023-03

2. Immunogenicity of Catch-Up Immunization with Conventional Inactivated Polio Vaccine among Japanese Adults;Vaccines;2022-12-15

3. Clinical evaluation of SARS-CoV-2 point-of-care antibody tests;Pathology;2020-12